Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis | MicrobiomeTrials
Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-02-25Est. Completion: 2027-06
Enrollment target: 119 participants
Locations
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing, Jiangsu, China
Other microbiome trials you might be interested in